Dashboard
1
The company has declared positive results for the last 2 consecutive quarters
- ROCE(HY) Highest at 8.17%
- DEBT-EQUITY RATIO (HY) Lowest at -57.11 %
- DEBTORS TURNOVER RATIO(HY) Highest at 2.29 times
2
With ROE of 7.38%, it has a fair valuation with a 2.92 Price to Book Value
3
Market Beating Performance
Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,534 Million (Mid Cap)
40.00
NA
2.42%
-0.57
8.11%
1.36
Revenue and Profits:
Net Sales:
509 Million
(Quarterly Results - Dec 2025)
Net Profit:
36 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.7%
0%
-2.7%
6 Months
8.53%
0%
8.53%
1 Year
27.58%
0%
27.58%
2 Years
37.08%
0%
37.08%
3 Years
-5.67%
0%
-5.67%
4 Years
20.14%
0%
20.14%
5 Years
-15.77%
0%
-15.77%
Beijing SDL Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.56%
EBIT Growth (5y)
21.05%
EBIT to Interest (avg)
39.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.55
Tax Ratio
15.26%
Dividend Payout Ratio
92.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.17%
ROE (avg)
8.40%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
2.92
EV to EBIT
34.55
EV to EBITDA
28.08
EV to Capital Employed
5.16
EV to Sales
4.15
PEG Ratio
4.58
Dividend Yield
1.18%
ROCE (Latest)
14.94%
ROE (Latest)
7.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
509.20
584.80
-12.93%
Operating Profit (PBDIT) excl Other Income
58.10
114.10
-49.08%
Interest
0.10
0.10
Exceptional Items
-7.30
-1.80
-305.56%
Consolidate Net Profit
36.20
93.60
-61.32%
Operating Profit Margin (Excl OI)
94.10%
178.20%
-8.41%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -12.93% vs 3.85% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -61.32% vs 16.56% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,389.60
1,412.10
-1.59%
Operating Profit (PBDIT) excl Other Income
216.90
202.50
7.11%
Interest
1.20
1.70
-29.41%
Exceptional Items
-20.40
-10.40
-96.15%
Consolidate Net Profit
151.80
169.60
-10.50%
Operating Profit Margin (Excl OI)
127.20%
115.10%
1.21%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.59% vs -5.94% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -10.50% vs -16.33% in Dec 2024
About Beijing SDL Technology Co., Ltd. 
Beijing SDL Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






